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Background: The genetic changes in gastric adenocarcinoma are extremely complex and reliable tumor markers
have not yet been identified. There are also remarkable geographical differences in the distribution of this disease.
Our aim was to identify the most differentially regulated genes in 20 gastric adenocarcinomas from a Norwegian
selection, compared to matched normal mucosa, and we have related our findings to prognosis, survival and
chronic Helicobacter pylori infection.
Methods: Biopsies from gastric adenocarcinomas and adjacent normal gastric mucosa were obtained from 20
patients immediately following surgical resection of the tumor. Whole genome, cDNA microarray analysis was
performed on the RNA isolated from the sample pairs to compare the gene expression profiles between the tumor
against matched mucosa. The samples were microscopically examined to classify gastritis. The presence of H. pylori
was examined using microscopy and immunohistochemistry.
Results: 130 genes showed differential regulation above a predefined cut-off level. Interleukin-8 (IL-8) and Claudin-1
(CLDN1) were the most consistently up-regulated genes in the tumors. Very high CLDN1 expression in the tumor
was identified as an independent and significant predictor gene of reduced post-operative survival. There were
distinctly different expression profiles between the tumor group and the control mucosa group, and the histological
subsets of mixed type, diffuse type and intestinal type cancer demonstrated further sub-clustering. Up-regulated
genes were mapped to cell-adhesion, collagen-related processes and angiogenesis, whereas normal intestinal
functions such as digestion and excretion were associated with down-regulated genes. We relate the current
findings to our previous study on the gene response of gastric epithelial cells to H. pylori infection.
Conclusions: CLDN1 was highly up-regulated in gastric cancer, and CLDN1 expression was independently
associated with a poor post-operative prognosis, and may have important prognostic value. IL-8 and CLDN1 may
represent central links between the gene response seen in acute H. pylori infection of gastric epithelial cells, and
ultimately gastric cancer.
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Gastric cancer (GC) is only second to lung cancer in
world-wide cancer-related deaths, however there are
great geographical differences in GC distribution. Data
from 2010 demonstrate that the GC incidence in
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reproduction in any medium, provided the or[1] compared to less developed areas, particularly in
Eastern Asia, where the incidence is approximately
6-fold (males 42.4, females 18.3 per 100.000) [2].
Gastric adenocarcinoma is remarkably heterogeneous
genetically, cytologically and architecturally compared to
other gastrointestinal carcinomas. The search for reliable
tumor markers and consistent prognostic indicators has
proven difficult. Several authors have attempted to
predict GC disease and prognosis based on single or
multiple genes [3-8], but there are discrepancies between
the studies, and currently no gene signature or bio-
markers are in routine clinical use. Understanding theLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Patient characteristics and clinicopathological
features of the 20 gastric tumors used in the study
Sex Females n = 5, males n = 15
Ethnicity Caucasian n = 18, Asian n = 2
Age at surgery Total: 68.7 years (±12.5)
Females: 65.7 years (±21.8)
Males: 69.7 years (±8.6)
Postoperative survival (deceased
individuals)
Total: 13.2 months (±8.8)
Females (n = 4): 16.6 months (±6.4)
Males (n = 10): 12.0 months (±9.7)
Postoperative survival (alive
individuals at study end)
Total: 45.8 months (±7.9)
Females (n = 1): 48.0 months
Males (n = 5): 44.9 months (±8.8)
Tumor size 49 mm (±27)








Histological type Intestinal 5
Diffuse 12
Mixed 3
Patient characteristics and clinicopathological features of the 20 gastric tumors
used in the study. Values are the mean plus/minus standard deviation.
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major challenges in cancer genomics. The Lauren classi-
fication divides adenocarcinomas into three different
histological subtypes: intestinal and diffuse types and a
mixed variant [9], which are thought to take different
pathways of carcinogenesis. The intestinal type is attrib-
utable to a multistep progression from chronic gastritis
through gastric atrophy, metaplasia, dysplasia and ultim-
ately malignant disease [10]. Diffuse types may arise
from chronic inflammation without a clear manifestation
of intermediate premalignant steps [11-13]. The mixed
type shows non-homogenous mixtures of both intestinal
and diffuse type architecture, and might represent a sep-
arate cancer category with exclusive gene mutations and
a more aggressive course [14,15]. In spite of extensive
research into the genetic changes of GC, the mecha-
nisms underlying the disease are still far from under-
stood, and the disease cannot easily be explained by
an adenoma-carcinoma model like in colorectal cancer.
There are three molecular mechanisms that drive gastric
carcinogenesis: Chromosome instability, microsatellite
instability and epigenetic alterations [16]. The net result
is activation of oncogenes, inactivation of tumor sup-
pressor genes and deregulation of signaling pathways
[11,12]. Aberrant cell cycle regulation and changes in
the expression of growth factors and cytokines regulate
differentiation and survival of tumor cells. Mutations of
cell-adhesion and angiogenic genes play important roles
in the invasive and metastatic behavior of GC cells.
The aim of the current study was to identify the most
differentially regulated genes in surgically resected gas-
tric adenocarcinoma compared to matched normal mu-
cosa, using whole genome cDNA microarray profiling.
We also attempt to identify genes which influence GC
prognosis and survival. The results are compared to the
gastric epithelial cell gene response to H. pylori infec-
tion, which was analyzed in a previously published paper
[17]. This study adds support to the significance of IL-8
and CLDN1 in gastric carcinogenesis, as well as demon-
strates important genetic changes in GC and their pos-
sible relevance to H. pylori infection.
Methods
Tissue and patient characteristics
Biopsies were obtained from patients diagnosed with non-
cardia gastric adenocarcinoma at the endoscopy out-
patient clinic at Akershus University Hospital, Norway.
Thoraco-abdominal computed tomography imaging was
undertaken to exclude patients with metastatic disease. 20
patients with both intestinal and diffuse types of GC were
included. Patients and clinicopathological characteristics
are presented in Table 1. On admission for elective
surgery, written, informed consent for participation in
the study was obtained from the participants. Within5 minutes of removal of the principal surgical specimen,
samples were taken from both the tumor border and from
healthy gastric corpal mucosa within the same stomach
area but more than 5 cm away from the tumor, and stored
on RNAlater (Applied Biosystems, USA). All samples were
stored in +4°C for approximately 1–2 weeks to allow
complete tissue penetration of RNAlater, before samples
were dried and permanently stored in −80°C. All sample
acquisition and handling were performed by the same
individual.
Following resection of the tumor, the principal speci-
men was subjected to histolopathological examination
by two senior specialist pathologists to confirm the diag-
nosis and classify the tumor according to the Lauren
classification [9]. Antral and corpal gastric mucosa were
examined for gastritis, atrophy and metaplasia, and the
presence or absence of H. pylori was microscopically ex-
amined and subsequently identified by immunohisto-
chemistry. The Updated Sydney System was used to
classify and grade the degree of gastritis [18,19].
The study was approved by the Norwegian Regional
Committee for Medical and Health Research Ethics
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coded and blinded before analysis.
RNA isolation, quality control and cDNA synthesis
Total RNA was isolated using the RNeasy Blood and
tissue kit (Qiagen GmBH, Germany) according to the
manufacturer’s standard preparation protocol. RNA
concentration and quality were determined using a
NanoDrop ND-1000 spectrophotometer (NanoDrop
Technologies, USA) and Agilent 2100 Bioanalyzer
(Agilent Technologies, USA). The RNA integrity num-
ber was adequate for cDNA synthesis.
The Illumina TotalPrep RNA amplification Kit
(Ambion Inc., USA) was used to amplify RNA for
hybridization on Illumina BeadChips. To synthesize first
strand cDNA by reverse transcription, we used total
RNA from each sample collected above. Following the
second strand cDNA synthesis and cDNA purification
steps, the in vitro transcription to synthesize cRNA was
prepared overnight for 12 hours.
cDNA oligonucleotide microarray analysis
The gene expression profiles were measured using Illu-
mina Human HT-12 v3 Expression BeadChip (Illumina,
USA), which enables genome-wide expression analysis
(48800 transcripts, corresponding to approximately 37800
genes) of 12 samples in parallel on a single microarray.
35967 of the probes were designed using the RefSeq (build
36.2, release 22) library and 12.837 probes were derived
from the UniGene (build 199) database [20,21].
Immunohistochemistry
The presence of H. pylori in the surgical specimens was
analyzed using a polyclonal anti-Helicobacter-antibody
(Dako, Denmark, code B0471, dilution 1:200). 4 μm sec-
tions of formalin-fixed, paraffin-embedded tissue from
non-tumorous mucosa were applied on coated slides.
Deparaffinization, rehydration and epitope retrieval were
performed in a Dako PT Link (Dako, Denmark) at
97°C for 20 min. The immunostaining procedure was
carried out in a Dako Autostainer Plus applying the
Envision™Flex, High pH system (Dako, Denmark).
Bioinformatics and statistics
R/BioConductor [22,23] with the package Beadarray [24]
were used for preprocessing of the microarray text data
from BeadStudio. Spatial artifacts were removed using
BASH [25] before the expression data were log2-trans-
formed and quantile normalized. The log2 fold change
(FC) of each probe on the array within each tissue pair
(tumor vs matched normal mucosa) was then calculated,
and the data were loaded into the J-express software
package [26]. Rank product testing [27] was then per-
formed to test whether the differential expressionbetween tumor tissue and matched normal mucosa was
significant. The differential expression was declared sig-
nificant if the adjusted p-value, i.e. the FDR q-value, was
less than 0.05. Hierarchical clustering was performed
using average linkage and Euclidean distance measure.
The analyses were performed using the J-express soft-
ware package [26].
To produce a reasonably sized list of the most differ-
entially expressed genes, lesser expressed genes were
filtered out at a cutoff level of FC > 1.5, producing a list
of the 130 most differentially expressed genes. This
dataset was imported into Onto-Express and Pathway
Express [28,29], part of the Onto-Tools software suite,
for functional analysis, and grouped into Gene Ontology
(GO) terms and KEGG (Kyoto Encyclopedia of Genes
and Genomes) cellular signaling pathways [30]. Pathway
Express calculates an Impact Factor (IF) which is used to
rank the affected signaling pathways, based on the fold
change, the number of the involved genes in the path-
way, and the amount of perturbation of downstream
genes [31].
The dataset was entered into PASW Statistics (SPSS
version 18.0.2) to perform bivariate correlation analysis
to select genes that associated with clinicopathological
parameters. Both Pearson and Spearman correlation co-
efficients were employed to identify correlating genes.
Among genes that correlated, we were particularly inter-
ested in those that showed a similar expression in our
previously published study of H. pylori-exposed gastric
epithelial cells [17]. The selected genes were then sub-
jected to a Cox multivariate regression analysis to inves-
tigate whether any of the genes were independent
predictors of post-operative survival in the GC patients,
independent of histological type, tumor stage and size,
nodal disease, and age at surgery. In the one predictor
gene that was identified, different cut-off levels were
applied to construct high and low expression level
groups, before statistical significance between the groups
was assessed using a log-rank (Mantel-Cox) test. A
Kaplan-Meier survival plot was created to demonstrate
the difference in survival between the high- and low-
expression groups.
The microarray data are available under the accession
number E-MTAB-1440 in the ArrayExpress database [32].
Results
Gene expression
Whole genome expression profiling of 20 matched
gastric tumor samples was performed using cDNA mi-
croarrays. Rank product statistical testing [27] of the
log2 fold change (FC) expression values of approximately
38000 genes on the microarray chip revealed 2297 genes
that were significantly up-regulated and 2259 genes that
were significantly down-regulated in the tumor tissue
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130 filtered genes which were differentially regulated by
an average FC > 1.5 are listed in Table 2, and constitute
the dataset on which further analysis is performed.
Of the most differentially regulated genes, 30 genes
demonstrated up-regulation and 100 genes were down-
regulated. IL-8 was the single most up-regulated gene,Table 2 The most differentially regulated genes in gastric tum
Up-regulated genes (n=30)
Gene symbol Average FC Gene symbol Average FC
IL-8 2.58 PGA4 -5.58
COL1A1 2.18 GIF -5.48
CLDN1 2.14 ATP4A -5.28
SPP1 2.09 PGA3 -4.72
CLDN2 2.09 ATP4B -4.71
CEACAM6 2.09 PGA5 -4.34
SERPINB5 2.06 LIPF -3.91
KRT17 2.00 CPA2 -3.78
H19 1.94 GHRL -3.75
CLDN7 1.93 GKN2 -3.26
TFF3 1.92 KCNE2 -3.19
OLFM4 1.91 SST -3.12
THBS2 1.91 CHGA -3.02
PI3 1.90 PSCA -3.00
SULF1 1.89 CHIA -2.88
BGN 1.82 GKN1 -2.88
KRT6B 1.80 KCNJ16 -2.82
THY1 1.72 GC -2.66
MMP11 1.70 CLIC6 -2.65
KLK6 1.67 SOSTDC1 -2.53
SERPINA3 1.65 ESRRG -2.52
FNDC1 1.64 CCKBR -2.51
COL1A2 1.63 TMED6 -2.44
CST1 1.63 MT1M -2.44
FAP 1.60 GPER -2.43
COL6A3 1.60 CKMT2 -2.36
SFRP4 1.56 VSIG2 -2.36
TMEM158 1.53 FLJ42875 -2.33
MMP7 1.50 CXCL17 -2.32





Differentially regulated genes with average log2FC of > 1.5 (n = 130). extracted from
are listed. Nine genes. shown in bold type. demonstrated similar regulation in both
exposed to H. pylori [17].up-regulated in 18 of 20 tissue pairs, with an average
FC of 2.6 (Figure 1), followed by COL1A1 and CLDN1
(Figure 2). The most down-regulated gene was PGA4,
being remarkably down-regulated in 18 of 20 tissue
pairs, followed by GIF and ATP4A. Hierarchical cluster-
ing of the dataset (Figure 3) showed that the tumor
and control tissues formed distinctly different geneor vs control mucosa
Down-regulated genes (n=100)
Gene symbol Average FC Gene symbol Average FC
MAL -2.22 AKR7A3 -1.79
SCNN1B -2.22 KIAA1324 -1.79
SOX21 -2.22 CCDC121 -1.78
CAPN9 -2.21 FBP2 -1.76
AGXT2L1 -2.20 FCGBP -1.75
HDC -2.18 ORM2 -1.75
GSTA1 -2.18 FAM3B -1.73
KLK11 -2.12 TRIM50 -1.73
APLP1 -2.12 DUOX1 -1.72
MT1H -2.09 RAP1GAP -1.70
ADH1C -2.09 EEF1A2 -1.70
DPCR1 -2.06 ANGPTL3 -1.70
AKR1B10 -2.03 B3GAT1 -1.69
MT1G -2.03 C6ORF105 -1.68
CKB -2.01 FGG -1.68
SH3GL2 -1.99 ADA -1.65
REP15 -1.97 C6ORF58 -1.63
CKM -1.95 ZNF533 -1.60
FGA -1.95 RPESP -1.59
SLC9A4 -1.92 MT1F -1.58
MFSD4 -1.92 PNPLA7 -1.57
ALDOB -1.89 FUT9 -1.57
SCNN1G -1.87 RPRM -1.56
IRX2 -1.87 GUCA2B -1.56
SLC26A9 -1.87 TCN1 -1.55
CLCNKA -1.87 PKIB -1.55
CAPN13 -1.86 SLC9A2 -1.55
TTR -1.86 HOMER2 -1.53
GSTA2 -1.85 AKR1C4 -1.50
NKX6-2 -1.83 REG3A -1.50
CA2 -1.83 PI16 -1.50
FOLR1 -1.82 MAP7D2 -1.50
RDH12 -1.81
IRX3 -1.80
whole genome expression. Average log2FC levels corresponding to each gene
the current study and in a previous study where gastric epithelial cells were
Figure 1 Interleukin-8 gene expression in gastric tumors vs matched control mucosa. The solid line represents the relative ratio of IL-8
expression in tumor tissue compared to matched control gastric mucosa, as the log2 fold change (log2 tumor/control expression levels). A
positive score indicates a higher expression in the tumor compared to the normal gastric mucosa. IL-8 was the most consistently up-regulated
gene in the study. The grey background represents the expression of approximately 37 800 other genes.
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ent histological categories diffuse, intestinal and mixed
cancer formed almost exclusive individual clusters, dem-
onstrating close genetic resemblance within each of the
histological subsets. Among the control tissues, and
among the H. pylori positive individuals, no particular
clustering was seen.
Genes from the current dataset were cross-matched
against the most differentially regulated genes identified
in our previous study, where gastric epithelial cells were
exposed to H. pylori for 24 hours in vitro [17]. Both
H. pylori-exposed gastric epithelial cells and the tumor
biopsies demonstrated significant up-regulation of five
common genes (IL-8, CLDN1, KRT17, CLDN7 andFigure 2 Claudin 1 gene expression in gastric tumors vs matched con
expression in the tumor tissue compared to matched control gastric muco
A positive score indicates a higher expression in the tumor compared to th
expression of approximately 37 800 other genes.MMP7) and down-regulation of four common genes
(GPER, KIAA1324, ADA and SLC9A2).
Gene ontology
Next, the dataset of the 130 most differentially regulated
genes was analyzed for functional annotation using GO
terms (Table 3). Among the 30 up-regulated genes,
cell-adhesion processes, and in particular calcium-
independent cell-cell adhesion, were among the most
highly enriched terms. Furthermore, synthetic processes
like skin morphogenesis and blood vessel development,
as well as both catabolic and synthetic collagen-related
processes were among the significant terms identified.
Only a smaller proportion of the down-regulated genestrol mucosa. The solid line represents relative ratio of CLDN1
sa, as the log2 fold change (log2 tumor/control expression levels).
e normal gastric mucosa. The grey background represents the
Figure 3 Hierarchical clustering of the gene expression of 20 gastric tumors and control mucosa. Whole genome expression of 20 tumor/
control tissue pairs were filtered to produce a dataset containing the 130 most differentially regulated genes. Most the tumor samples clustered
separate to the control samples. The diffuse type tumor samples are highlighted in light grey, the intestinal type in medium grey and the mixed
type in dark grey to illustrate the subclustering of the three different histological cancer types.
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Table 3 Gene ontology associations in up-regulated genes
P-value No of genes involved % of genes involved Gene ontology GO:number
0.00066 3 10.0 Calcium-independent cell-cell adhesion GO:0016338
0.0007 2 6.67 Skin morphogenesis GO:0043589
0.023 5 16.67 Cell adhesion GO:0007155
0.023 2 6.67 Collagen catabolic process GO:0030574
0.023 2 6.67 Collagen fibril organization GO:0030199
0.027 2 6.67 Blood vessel development GO:0001568
0.042 1 3.33 Copulation GO:0007620
0.042 1 3.33 Regulation of retroviral genome replication GO:0045870
0.042 1 3.33 Responsen to corticosteroid stimulus GO:0031960
0.042 1 3.33 Tooth mineralization GO:0034505
Significantly enriched Gene Ontology terms in the up-regulated genes from the dataset.
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regulated genes, where digestion and excretion were the
most enriched terms. Several metabolic processes, pH
regulation and cobalamin and ion transport were also
significantly enriched GO terms amongst the down-
regulated genes (Table 4).
KEGG cellular signaling pathways
The dataset was then analyzed for KEGG cellular signal-
ing pathway associations. 11 of the 30 up-regulated
genes were mapped to 8 significant KEGG pathways
(p < 0.05). In particular the cell adhesion molecules
(CAM) pathway and leukocyte transendothelial migra-
tion pathway were assigned a high impact factor, due to
the strong up-regulation of CLDN1, CLDN7, and THY1
genes, and the high relative impact of these genes on the
CAM pathway. IL-8, COL1A1, COL1A2, THBS2, SPP1,
COL6A3 and SFRP4 were mapped to several highly im-
pacted pathways: leukocyte transendothelial migration,
extracellular matrix receptor interaction, tight junction,
epithelial cell signaling in H. pylori infection, TGFβ
signaling pathway, toll-like receptor signaling and WntTable 4 Gene ontology associations in down-regulated genes











Significantly enriched Gene Ontology terms in the down-regulated genes from thesignaling (Table 5). None of the 100 down-regulated
genes were mapped to any significant KEGG pathways.
Clinicopathological correlation
Among the total set of the 130 most differentially regu-
lated genes, the FC expression levels of 20 genes showed
significant correlation with post-operative survival, 8
genes correlated with histological type, 5 genes corre-
lated with tumor size, and 1 gene correlated with lymph
node stage (Additional file 1). Some genes showed
correlation with more than one parameter. Because of
the moderate sample size (n = 20), a significance level of
p < 0.01 was chosen.
Cox multivariate analysis of the genes associated with
post-operative survival demonstrated that a high CLDN1
expression level was the only independent predictor
gene of post-operative survival. CLDN1 expression and
the covariates tumor size, positive lymph node fraction,
histological type, gender and age at surgery were entered
into a linear regression model (Table 6), demonstrating
that only CLDN1 and positive lymph node fraction were
significant predictors of post-operative survival. WhenGene ontology GO:number
Digestion GO:0007586
Excretion GO:0007588
Creatine metabolic process GO:0006600
Cellular aldehyde metabolic process GO:0006081




Cobalt ion transport GO:0006824
Morphogenesis of an epithelium GO:0002009
dataset.
Table 5 KEGG cellular signaling pathways
Rank Pathway name IF P-value
1 Cell adhesion molecules (CAMs) 734.0 0.000129
2 Leukocyte transendothelial migration 672.1 0.000879
3 ECM-receptor interaction 10.9 0.00215
4 Tight junction 10.6 0.000296
5 Epithelial cell signaling in Helicobacter 7.2 0.006
6 TGF-beta signaling pathway 6.3 0.013
7 Focal adhesion 6.2 0.014
8 Calcium signaling pathway 5.1 0.035
Significantly enriched KEGG cellular signaling pathways in the dataset
(p < 0.05). Impact Factor (IF) is used to rank the affected signaling pathways,
based on the fold change, the number of the involved genes in the pathway,
and amount of perturbation of downstream genes.
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was a stronger negative correlation between CLDN1 ex-
pression and post-operative survival (R = −0.7, p < 0.001).
There were no significant association between CLDN1
expression and Lauren classification, H. pylori infection,
ethnicity, tumor size or metastatic lymph node status.
To detect differences in post-operative survival be-
tween individuals with high and low CLDN1-expressing
tumors, different cut-off levels were utilized to create
high-expressing and low-expressing groups. Using the
CLDN1 FC mean (FC mean = 2.14) as the group divider,
high- and low-expressing CLDN1 patients demonstrated
significantly different survival patterns (p < 0.001) as
illustrated in the Kaplan-Meier plot in Figure 4.
Histopathological features of adjacent non-cancerous
mucosa
Of the 20 matched mucosa specimens, 10 showed evi-
dence of non-atrophic gastritis, and 10 demonstrated
multifocal atrophic gastritis. Intestinal metaplasia was
scored from 1–3 in the antrum and corpus areas of the
samples. The intestinal type tumors were significantly
associated with both atrophic gastritis and intestinal
metaplasia (p < 0.001), whereas the diffuse type tumorsTable 6 Factors influencing survival following surgery for
gastric cancer




Lymph node fraction −0.46 0.016
Tumor size −0.27 0.186
Age at surgery −0.13 0.491
Histological type (intestinal type) −0.03 0.888
Male gender −0.05 0.792
Linear regression analysis of multiple factors influencing post-operative
survival in patients undergoing surgery for gastric cancer.were associated with non-atrophic gastritis (p < 0.001).
Both histological and immunohistochemical evidence of
H. pylori were demonstrated in the mucosa counterpart
of 1 intestinal and 1 diffuse type cancers (Figures 5
and 6), both in caucasian patients. The other 18 speci-
mens showed no evidence of H. pylori. There were no sig-
nificant differences between types of cancers, types of
gastritis, or the presence of H. pylori on the one hand, and
the correlation with the gene expression of CLDN1 or IL-8.
Discussion
In this study we identified CLDN1 as one of the most
consistently up-regulated genes in GC and a strong cor-
relation between up-regulation of CLDN1 and reduced
survival in 20 patients with gastric adenocarcinomas.
This correlation is even stronger when adjusted for other
parameters such as lymph node stage, tumor size and
histological type. Our clinical sample size is small, but
the results are consistent.
Claudins are proteins involved in cellular tight junc-
tions and are important for the maintenance of normal
epithelium, in particular barrier formation, cell polarity
and signal transduction. Dysregulation of these genes
have been identified in many different cancers. Based on
tumor biology, down-regulation of CLDN1 would result
in destruction of tight junctions and loss of cell-to-cell
adhesion causing tumor progression [33], however the
clinical significance in gastric carcinogenesis is more
complex. There is evidence that several of the claudins,
CLDN1 included, show increasing levels as gastric epi-
thelium progresses to intestinal metaplasia and early
gastric carcinoma [34]. CLDN1 might influence intracel-
lular signalling, demonstrated by Liu et al. who showed
that elevated expression of CLDN1 in breast cancer cells
contributed to an anti-apoptotic effect through two
mechanisms: inhibition of caspase-8 cleavage, and acti-
vation of the Wnt/β-catenin signal pathway [35]. CLDN1
has been identified within the nucleus of gastric cancer
AGS cells in vitro, suggesting a regulatory role of
CLDN1 on cell proliferation, migration and invasiveness
at a nuclear level [36]. Some studies on ovarian and
colon cancer report a role of CLDN1 on metastatic pro-
cesses through activation of metalloproteinases, reducing
apoptosis and increasing migration [36]. Although there
are several papers to support an oncogenic role of
CLDN1 in gastric cancer, two studies nevertheless
showed reduced CLDN1 staining in metastatic com-
pared to non-metastatic gastric cancer [33], and
increased tumorgenicity in CLDN1 negative gastric epi-
thelial cells [37], contrasting our findings.
The expression pattern of CLDN1 differs not only
between different stages of carcinogenesis, but also
between histological subtypes and between regions of
























Figure 4 Kaplan Meier survival plot of patients with resected gastric tumors. The solid line represents below average CLDN1-expressing
tumors (FC < 2.14) and the dotted line represents above average CLDN1-expressing tumors (FC > 2.14). 6 patients in the low CLDN1-expressing
group were still alive at the end of the study period, as demonstrated by the solid line vertical tics.
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pared to diffuse type gastric cancer [38]. In contrast,
Jung et al. demonstrated significantly lower CLDN1
expression in intestinal compared to diffuse type [33].
Neither studies found any correlation between CLDN1
and prognosis. Wu et al. demonstrated positive correl-
ation between CLDN1 expression and invasiveness and
metastasis in gastric tumors using immunohistochemis-
try [39]. In two studies on colorectal cancer, low expres-
sion of CLDN1 was a predictor of poor prognosis
[40,41], however an association between high CLDN1
expression and depth of tumor invasion was also noted
[41]. In summary, the role of CLDN1 in cancer progres-
sion and prognosis is far from clear.Figure 5 Histological section of H. pylori induced non-atrophic
chronic gastritis. The arrow points out an area of active
inflammation with characteristic granulocytic infiltration in the
crypt epithelium.Our data demonstrate a marked increase in CLDN1
expression in 19 of 20 tumors compared to normal
tissue, with a significant and independent relationship
between high CLDN1 expressing tumors and reduced
postoperative survival. We found no statistically signifi-
cant difference between CLDN1 expression and histo-
logical subtypes, for that our sample number is
insufficient. Nevertheless, tumors with high CLDN1 ex-
pression (FC > 2.14) showed an extremely poor progno-
sis as there were no patients alive at 450 days following
curatively intended surgery in this group. In the low-
expressing CLDN1 group (FC < 2.14), patients showed
significantly longer post-operative survival, and 50% of
the patients were still alive at the end of the study. WeFigure 6 Immunohistological evidence of H. pylori. H. pylori
was discovered in 2 of the 20 mucosa samples. The specimen
from Figure 5 has been subjected to immunohistochemistry
treatment by anti-Helicobacter-antibody, staining H. pylori brown.
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mortality. Our sample number is small, and a much lar-
ger study would be required to reveal statistically signifi-
cant correlation between CLDN1 expression and sample
subgroups, such as the histological subtypes, different
tumor stages and H. pylori status. The role of CLDN1 in
gastrointestinal cancer is controversial, but it seems con-
vincing that the high CLDN1 gene expression conferred
a very unfavorable prognosis in our study population.
Moreover, CLDN1 was also one of the most significantly
up-regulated genes in the previously studied H. pylori-
exposed gastric epithelial cells [17], suggesting a possible
causal relationship between chronic H. pylori exposure
and CLDN1 up-regulation in gastric mucosa.
Other claudins that were up-regulated in the tumor
samples were CLDN2 and CLDN7, and these genes
might also be implicated in gastric carcinogenesis
[36,42-48]. CLDN7 was also among the most signifi-
cantly up-regulated gene in the H. pylori exposed gastric
epithelial cells [17], suggesting a role of this bactierium
in the regulation of this gene.
The most consistently increased gene in the study was
IL-8, up-regulated in the tumor in 18 of 20 tissue pairs.
IL-8 is one of the major mediators of inflammation and
a powerful chemokine that targets neutrophils and lym-
phocytes through the receptors CXCR1 and CXCR2.
IL-8 is paramount in the acute inflammatory response to
H. pylori infection and is also increased in chronic gas-
tritis [49]. The increased IL-8 expression in the tumor
samples may represent intratumoral inflammation as a
normal reaction to an abnormal environment. However,
the absence of other acute or chronic inflammatory
genes suggests that the up-regulated IL-8 in the tumors
can not be entirely explained by an inflammatory
process alone. Hence, the role of IL-8 in the gastric can-
cer is not clear. First, persistent and chronic inflamma-
tion in the stomach is associated with an enhanced
production of several pro-inflammatory cytokines in-
cluding IL-8 [50] which increases apoptosis, hyperproli-
feration and production of reactive oxygen and nitrogen
species causing DNA damage and mutations. Second, in-
creased vascularization is one of the hallmarks of malig-
nant transformation, and IL-8 may serve an important
role in this process. Several authors have demonstrated
promotion of angiogenesis in tissue exposed to IL-8 pro-
tein [51-53]. A plausible causal role of IL-8 in the
growth and vascularization of gastric cancer has also
been shown in the work of Kitadai et al., where IL-8
transfected cells that were injected into the gastric wall
of mice, rapidly produced growth of highly vascularized
tumors [54]. Interestingly, we also found significantly in-
creased and coordinated up-regulation of COL1A1 and
COL1A2 in the tumor tissue, both of which are import-
ant in blood vessel development. Two authors recentlyfound an association between IL-8 and adhesion, migra-
tion, and invasion in gastric cancer cells [55,56]. Target-
ing of the IL-8 receptor CXCR2 has been suggested as a
novel cancer treatment in several studies [53,55-57].
In our previous study we identified IL-8 as the single
most up-regulated gene in the acute response of gastric
epithelial cells exposed to H. pylori in vitro [17]. IL-8 is
also up-regulated in the pre-malignant stages of gastric
cancer, such as chronic gastritis [58] and intestinal meta-
plasia [59]. With IL-8 being currently demonstrated as
the single most up-regulated gene in surgically resected
GC tumors, the up-regulation of this gene throughout
gastric cancer progression may constitute an early and
important event in the disease, initiated and maintained
by H. pylori infection.
The causal relationship between H. pylori colonization
of the stomach and GC has been widely accepted [60].
In this study only 2 of the 20 gastric tumors showed ac-
tive H. pylori infection at the time of surgery, 1 intestinal
and 1 diffuse type cancer. While more than 90% of the
GC reported in Asian countries are considered attribut-
able to this bacterium [61], our findings might indicate a
lesser role of H. pylori in gastric cancer in a country like
Norway. However, GC tissue is frequently H. pylori
negative, due to the mucosal atrophy caused by the bac-
teria itself. While H. pylori colonization drives forward
the progression of mucosal atrophy and intestinal meta-
plasia, this process paradoxically also slowly eradicates
the same bacteria from the gastric mucosa which causes
a decrease in active inflammation [62].
In the current study, we demonstrated up-regulation
of several matrix metalloproteinases (MMPs); and
KRT17 in the tumor of almost all the tissue pairs. MMPs
participate in the degradation of extracellular matrix and
the regulation of tumor growth and angiogenesis, and
are important in the detachment of malignant cells from
adjacent tissue to attain metastatic ability. Keratin 17
has been shown to be over-expressed in several adeno-
carcinomas including GC, and an association with ag-
gressive tumor behaviour, local invasion, metastasis as
well as treatment responsiveness has also been suggested
[63-65]. We found no assiciation between MMPS and
KRT17 and clinicopathological parameters. However,
other studies have demonstrated an association with
MMPs and advanced tumor stage, high grade tumors
and metastasis, as well as a role for MMP11 as a serum
marker in GC disease [66-69]. MMP7 and KRT17 were
also among the most up-regulated genes our previous
study of gastric epithelial cells exposed to H. pylori [17],
which raises the possibility of a role of H. pylori also in
the regulation of these genes.
In hiarchical clustering of the samples, the tumor and
the control tissues clustered separately. Normal mucosa
tissue bore a closer biological resemblance to normal
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counterpart from its own stomach. In similar fashion,
most tumor samples clustered together, demonstrating
common genetic features between the tumor specimens.
In addition, there was a large horizontal distance be-
tween the tumor specimen and the normal specimen
within each tissue pair, illustrating that a significant shift
in gene expression has occurred during the progression
from normal mucosa to cancer within the same stom-
ach. Furthermore, the mixed type and the intestinal type
of cancers formed two almost exclusive clusters com-
pared to the diffuse type cancers, indicating that each of
the histological types have distinct gene expression pro-
files. Surprisingly, the mixed type cluster showed the
greatest difference in gene expression compared to the
normal tissue, indicating that the biology of this type of
GC has removed itself the most from the original naive
tissue. The results are interesting, but the sample num-
ber is too small to draw any conclusions.
We performed GO analyses to cluster the most differ-
entially regulated genes according to biological function.
Several terms relating to cell adhesion were enriched by
genes up-regulated in the tumor samples. KEGG path-
way analysis also showed that a number of pathways
regulating cell attachment were significantly affected, in
agreement with the GO analysis. Disruption of primary
cell attachments, and secondly, cell adhesion to distant
sites, are two fundamental steps in the ability of tumor
cells to develop metastatic disease. Blood vessel develop-
ment is essential for the tumor’s ability to survive and
metastasize to distant sites. This gain of abilities seems
to come at the cost of loss of features of differentiated
intestinal tissue, such as digestive and excretive pro-
cesses, which were associated with down-regulated
genes. While several of the highly up-regulated genes
were mapped to important pathways, none of the 100
down-regulated genes were involved in any significant
pathways, indicating that it is the net gain of oncological
function that translates into tumor growth and malig-
nant behavior, rather than the loss of tumor suppression.
Conclusion
In our study, CLDN1 was not only highly up-regulated
in the gastric cancer samples, but CLDN1 expression
was also independently associated with a very poor
post-operative prognosis. IL-8 was the single most up-
regulated gene in the study, and we have shed new light
on the role of both genes in gastric carcinogenesis. IL-8
and CLDN1 may represent important links between GC
and the gene response seen in acute H. pylori infection
of gastric epithelial cells. Intestinal, diffuse and mixed
type of gastric cancer formed separate gene expression
clusters, but also showed many genetic similarities.
Functional analysis demonstrated that several cellularpathways regulating cell attachment were affected in the
tumor tissue.
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